HealthEquity, Inc. (NASDAQ:HQY) Q2 2024 Earnings Conference Call September 5, 2023 4:30 PM ET
Company Participants
Richard Putnam - Investor Relations
Jon Kessler - President & Chief Executive Officer
James Lucania - Incoming Chief Financial Officer
Tyson Murdock - Executive Vice President & Chief Financial Officer
Steve Neeleman - Vice Chair & Founder of the Company
Conference Call Participants
Greg Peters - Raymond James
Stan Berenshteyn - Wells Fargo
Glen Santangelo - Jefferies
Sean Dodge - RBC Capital Markets
Scott Schoenhaus - Stephans
Allen Lutz - Bank of America
George Hill - Deutsche Bank
Mark Marcon - Baird
David Larsen - BTIG
Sandy Draper - Guggenheim
Operator
Hello, everyone, and welcome to the conference. Please note today's conference is being recorded. I'd now like to turn the call over to Richard Putnam. Please go ahead.
Richard Putnam
Thank you, Rocco. Hello, everyone. Welcome to HealthEquity's Second Quarter of Fiscal Year 2024 Earnings Call. My name is Richard Putnam, Investor Relations for HealthEquity. Joining me today on the call is Jon Kessler, President and CEO; Dr. Steve Neeleman, Vice Chair and Founder of the Company; the Company's CFO, Tyson Murdock; and is soon to be CFO, James Lucania.
Before I turn the call over to Jon, I have 2 important reminders. A press release announcing the financial results for our second quarter of fiscal 2024 was issued after the market closed this afternoon. These financial results include the contributions from our wholly owned subsidiaries and accounts that they administer. The press release also includes definitions of certain non-GAAP financial measures that we will reference today. A copy of today's press release, including reconciliations of these non-GAAP measures with comparable GAAP measures and a recording of this webcast can be found on our Investor Relations website, which is ir.healthequity.com. Second, our comments and responses to your questions today reflect management's view as of today, September 5, 2023, and will contain forward-looking statements as defined by the SEC, which include predictions, expectations, estimates or other information that might be considered forward-looking. There are many important factors relating to our business, which could affect the forward-looking statements made today. These forward-looking statements are subject to risks and uncertainties that may cause the actual results to differ materially from statements made here today. We caution against placing undue reliance on these forward-looking statements, and we also encourage you to review the discussion of these factors and other risks that may affect our future results or the market price of our stock as they are detailed in our latest annual report on Form 10-K and subsequent periodic reports filed with the SEC. We assume no obligation to revise or update these forward-looking statements in light of new information or future events.